Life Sciences: Evidence Based Reimbursement
Nic Lochlainn Consulting Ltd, founded by Dr Eimear Nic Lochlainn, specialises in providing evidence based strategic market access advice to support the health economic positioning and reimbursement of new pharmaceuticals and payers’ clinical and economic evidence requirements.
Eimear has extensive international experience within the pharmaceutical industry, both of clinical development and reimbursement and market access strategies. Coupled with experience with the Scottish Medicines Consortium (SMC), Nic Lochlainn Consulting is perfectly positioned to offer clients a unique insight into reimbursement. Read more about Eimear Nic Lochlainn's background>.
Having sat on both sides of the reimbursement fence (industry and healthcare payers), Eimear clearly understands both the demands on clinical teams to achieve their regulatory approval goals and the demands on market access teams to fulfil the reimbursement evidence requirements of payers. With proven technical statistical and health economic expertise, immense experience of trial design, clinical development and reimbursement, Nic Lochlainn Consulting provides an in-depth consultation service to European, UK and US clients. Read more about Nic Lochlainn Consulting's services>.
Dr G Vincze,
The level of detail and insights were spot on...a highly valued expert...
Novartis Pharma AG